Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Rubenstein

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|August 12, 2024
Fremanezumab-associated injection site alopeciaMark Esguerra, Emily Rubenstein Engel
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 14, 2019
IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trialEmily Rubenstein Engel, Joshua Cheng
BMJ Case Reports|February 2, 2023
Amelioration of trichotillomania with onabotulinumtoxinA for chronic migraineEmily Rubenstein Engel, Jeremy-Ann Ham
Cutis|August 23, 2023
Porocarcinoma Development in a Prior Trauma SiteChristopher White, Michael McBride, Emily Rubenstein
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 14, 2013
A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraineEmily Rubenstein Engel, David Kudrow, Alan M Rapoport
International Journal of Dermatology|July 13, 2010
Botryomycosis-like pyoderma in the genital region of a human immunodeficiency virus (HIV)-positive man successfully treated with dapsoneEmily Rubenstein, Eliana Krulig, Vanessa Cardenas, et al.
Headache|September 6, 2016
Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 StudyStephen D Silberstein, Laszlo L Mechtler, David B Kudrow, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|August 12, 2024
Fremanezumab-associated injection site alopeciaMark Esguerra, Emily Rubenstein Engel
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 14, 2019
IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trialEmily Rubenstein Engel, Joshua Cheng
BMJ Case Reports|February 2, 2023
Amelioration of trichotillomania with onabotulinumtoxinA for chronic migraineEmily Rubenstein Engel, Jeremy-Ann Ham
Cutis|August 23, 2023
Porocarcinoma Development in a Prior Trauma SiteChristopher White, Michael McBride, Emily Rubenstein
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 14, 2013
A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraineEmily Rubenstein Engel, David Kudrow, Alan M Rapoport
International Journal of Dermatology|July 13, 2010
Botryomycosis-like pyoderma in the genital region of a human immunodeficiency virus (HIV)-positive man successfully treated with dapsoneEmily Rubenstein, Eliana Krulig, Vanessa Cardenas, et al.
Headache|September 6, 2016
Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 StudyStephen D Silberstein, Laszlo L Mechtler, David B Kudrow, et al.
Pageof 1